(S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (ADJP (RB molecularly) (VBN targeted)) (NN drug) (NNS perturbations))) (PP (IN on) (NP (JJ cellular) (NNS activities) (CC and) (NNS fates)))) (VP (VBP are) (ADJP (JJ difficult) (SBAR (S (VP (TO to) (VP (VB predict) (S (VP (VBG using) (NP (NP (NN intuition)) (ADVP (RB alone)))))))))) (PP (IN because) (IN of) (NP (NP (DT the) (JJ complex) (NNS behaviors)) (PP (IN of) (NP (JJ cellular) (JJ regulatory) (NNS networks)))))) (. .))
(S (NP (NP (DT An) (NN approach)) (PP (TO to) (S (VP (VBG overcoming) (NP (DT this) (NN problem)))))) (VP (VBZ is) (S (VP (TO to) (VP (VB develop) (NP (NP (JJ mathematical) (NNS models)) (PP (IN for) (S (VP (VBG predicting) (NP (NN drug) (NNS effects)))))))))) (. .))
(S (NP (JJ Such) (DT an) (NN approach)) (VP (NNS beckons) (PP (IN for) (NP (NP (NN co-development)) (PP (IN of) (NP (NP (JJ computational) (NNS methods)) (PP (IN for) (S (VP (VBG extracting) (NP (NP (NNS insights)) (ADJP (JJ useful) (PP (IN for) (S (VP (VP (VBG guiding) (NP (NN therapy) (NN selection))) (CC and) (VP (VBG optimizing) (NP (NN drug) (NN scheduling)))))))))))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (CC and) (VBP evaluate) (NP (NP (DT a) (JJ generalizable) (NN strategy)) (PP (IN for) (S (VP (VBG identifying) (NP (NP (NN drug) (VBG dosing) (NNS schedules)) (SBAR (WHNP (WDT that)) (S (VP (VBP minimize) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN drug))) (VP (VBN needed) (S (VP (TO to) (VP (VB achieve) (NP (NP (VBN sustained) (NN suppression) (CC or) (NN elevation)) (PP (IN of) (NP (NP (DT an) (JJ important) (JJ cellular) (NN activity/process)) (, ,) (NP (NP (DT the) (NN recycling)) (PP (IN of) (NP (JJ cytoplasmic) (NNS contents))) (PP (IN through) (NP (PRN (-LRB- -LRB-) (NN macro) (-RRB- -RRB-)) (NN autophagy))))))))))))))))))))) (. .))
(S (NP (NP (JJ Therapeutic) (NN targeting)) (PP (IN of) (NP (NN autophagy)))) (VP (VBZ is) (ADVP (RB currently)) (VP (VBG being) (VP (VBN evaluated) (PP (IN in) (NP (JJ diverse) (JJ clinical) (NNS trials))) (CC but) (PP (IN without) (NP (NP (DT the) (NN benefit)) (PP (IN of) (NP (DT a) (NN control) (NN engineering) (NN perspective)))))))) (. .))
(S (S (VP (VBG Using) (NP (NP (NP (DT a) (JJ nonlinear) (JJ ordinary) (JJ differential) (NN equation) (PRN (-LRB- -LRB-) (NNP ODE) (-RRB- -RRB-)) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ accounts) (PP (IN for) (NP (NP (ADJP (VBG activating) (CC and) (JJ inhibiting)) (NNS influences)) (PP (IN among) (NP (NP (NP (NN protein) (CC and) (JJ lipid) (NNS kinases)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NNS autophagy)))))) (PRN (-LRB- -LRB-) (NP (NNP MTORC1) (, ,) (NNP ULK1) (, ,) (NNP AMPK) (CC and) (NNP VPS34)) (-RRB- -RRB-)))))))))) (CC and) (NP (NP (NNS methods)) (VP (VBN guaranteed) (S (VP (TO to) (VP (VB find) (NP (ADJP (RB locally) (JJ optimal)) (NN control) (NNS strategies)))))))))) (, ,) (NP (PRP we)) (VP (VBP find) (NP (NP (JJ optimal) (NN drug) (VBG dosing) (NNS schedules)) (PRN (-LRB- -LRB-) (NP (JJ open-loop) (NNS controllers)) (-RRB- -RRB-)) (PP (IN for) (NP (NP (DT each)) (PP (IN of) (NP (NP (NP (CD six) (NNS classes)) (PP (IN of) (NP (NNS drugs)))) (CC and) (NP (NN drug) (NNS pairs)))))))) (. .))
(S (NP (PRP$ Our) (NN approach)) (VP (VBZ is) (ADJP (JJ generalizable) (PP (TO to) (S (VP (VBG designing) (NP (NP (UCP (NN monotherapy) (CC and) (JJ multi)) (NN therapy) (NN drug) (NNS schedules)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (JJ different) (NN cell) (VBG signaling) (NNS networks)) (PP (IN of) (NP (NN interest))))))))))))) (. .))
